Hovione is recognized as a Top Employer 2023
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Hovione is closer to its customers with a new website in Mandarin
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
Hovione has completed significant expansions at its facilities in New Jersey, USA, and Cork, Ireland.
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
Irish Examiner, 21 june 2021
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®